Andrew Ellis obtained his undergraduate and postgraduate qualifications at the University of Melbourne has been an honorary Research Fellow with the Department of Medicine University of Melbourne and Senior Scientist in Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg Victoria since 2004.
He possesses extensive experience in the quantitation of drug/hormone/biomarkers in biological matrices and manages the Clinical Pharmacology and Therapeutics laboratory that has a long history of basic and clinical neuroscience research and of providing accredited pathology services analysing biogenic amines and therapeutic drug monitoring test services.
Andrew has a background in chemotherapy clinical trial research and specialises in chromatography- and mass spectrometry-based analysis and pharmacokinetics. He is currently actively involved in a variety of local and national collaborative clinical research studies and is a member of the Steering Committee for ‘Autonomic Effects in Spinal Cord Injury’, and a member of the Executive Group for ‘the eGFR Study: Accurate Assessment of Renal Function in Indigenous Australians’. In addition Andrew is experienced in: stability testing procedures for pharmaceutical formulations, the development of tailored methods for analysis of new and established drugs in biological samples, and clinical trial and accredited laboratory protocol preparation and regulatory guideline adherence.
Find out more about Andrew Ellis' experience
Andrew Ellis' highlights
FEATURED Journal article
Plasma-Lyte 148 vs. Hartmann's solution for cardiopulmonary bypass pump prime: a prospective double-blind randomized trial
Read moreAndrew Ellis' selected work
Dilute, derivatise and shoot: Measurement of urinary free metanephrines and catecholamines..
Journal article
Comparison of creatinine and cystatin C based eGFR in the estimation of glomerular filtrat..
Journal article
Hyperfiltration in Indigenous Australians with and without diabetes
Journal article
Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs
Journal article
Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis
Journal article
Adding Measures of Body Composition to the CKD-EPI GFR Estimating Equation in Indigenous A..
Journal article
Andrew Ellis' selected work
Projects
Grant funding toward establishing Tandem Mass Spectrometry Capability to support biomedical research at the Austin Health precinct, 2009:
§The Austin Health and Medical Research Foundation
§ The University of Melbourne Faculty of Medicine, Dentistry and Health Sciences Equipment grant $75k
§ The Victorian Neurotrauma Initiative (VNI) – ANS in Spinal Cord Injury grant $20k
§ The Ian Potter Foundation 00k
§ The Ramaciotti Foundation $50k
§ The Collie Foundation $50k
§ The Urqhart Foundation $50k
Austin Health Medical Research Foundation. Stability of a capsule formulation of N-acetylcysteine for use in the prevention of contrast-induced nephropathy. 2005/6 0k.
SHPA (Society of hospital Pharmacists of Australia) DBL Development Fund. Stability of flucloxacillin in hospital in the home (determining the stability of flucloxacillin as used in hospital in the home) 2008 0k
SHPA (Society of hospital Pharmacists of Australia). Stability, safety and suitability of prefilled metaraminol syringes – Roche Research Grant on quality and Safety 2010 0k
Scholarly Works
Displaying the 10 most recent scholarly works by Andrew Ellis.
Keyword Analysis
Credentials
Positions
Positions
Honorary
Medicine - Austin Health
Associate Member
Australian Association of Clinical Biochemists
Member
Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists
Education
Education
Graduate diploma Information Technology
Royal Melbourne Institute of Technology
Master of Science
University of Melbourne
Bachelor of Science (Honours)
University of Melbourne